CN115872911B - Method for synthesizing selenomethylselenocysteine - Google Patents
Method for synthesizing selenomethylselenocysteine Download PDFInfo
- Publication number
- CN115872911B CN115872911B CN202111134725.6A CN202111134725A CN115872911B CN 115872911 B CN115872911 B CN 115872911B CN 202111134725 A CN202111134725 A CN 202111134725A CN 115872911 B CN115872911 B CN 115872911B
- Authority
- CN
- China
- Prior art keywords
- triflate
- selenomethylselenocysteine
- stirring
- solvent
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 10
- XDSSPSLGNGIIHP-VKHMYHEASA-N Se-methyl-L-selenocysteine Chemical compound C[Se]C[C@H]([NH3+])C([O-])=O XDSSPSLGNGIIHP-VKHMYHEASA-N 0.000 title claims description 33
- 238000003756 stirring Methods 0.000 claims abstract description 37
- 238000006243 chemical reaction Methods 0.000 claims abstract description 35
- VRDKYJSLDJDLML-UHFFFAOYSA-N methylselenol Chemical compound [Se]C VRDKYJSLDJDLML-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 18
- 238000001914 filtration Methods 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000010438 heat treatment Methods 0.000 claims abstract description 12
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims abstract description 8
- 230000003472 neutralizing effect Effects 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 20
- ANSUDRATXSJBLY-VKHMYHEASA-N methyl (2s)-2-amino-3-hydroxypropanoate Chemical compound COC(=O)[C@@H](N)CO ANSUDRATXSJBLY-VKHMYHEASA-N 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- 239000012043 crude product Substances 0.000 claims description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- FKOASGGZYSYPBI-UHFFFAOYSA-K bis(trifluoromethylsulfonyloxy)alumanyl trifluoromethanesulfonate Chemical compound [Al+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F FKOASGGZYSYPBI-UHFFFAOYSA-K 0.000 claims description 3
- UCYRAEIHXSVXPV-UHFFFAOYSA-K bis(trifluoromethylsulfonyloxy)indiganyl trifluoromethanesulfonate Chemical compound [In+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F UCYRAEIHXSVXPV-UHFFFAOYSA-K 0.000 claims description 3
- SBTSVTLGWRLWOD-UHFFFAOYSA-L copper(ii) triflate Chemical compound [Cu+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F SBTSVTLGWRLWOD-UHFFFAOYSA-L 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 claims description 3
- CITILBVTAYEWKR-UHFFFAOYSA-L zinc trifluoromethanesulfonate Chemical compound [Zn+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F CITILBVTAYEWKR-UHFFFAOYSA-L 0.000 claims description 3
- NYENCOMLZDQKNH-UHFFFAOYSA-K bis(trifluoromethylsulfonyloxy)bismuthanyl trifluoromethanesulfonate Chemical compound [Bi+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F NYENCOMLZDQKNH-UHFFFAOYSA-K 0.000 claims description 2
- PHSMPGGNMIPKTH-UHFFFAOYSA-K cerium(3+);trifluoromethanesulfonate Chemical compound [Ce+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F PHSMPGGNMIPKTH-UHFFFAOYSA-K 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- HZXJVDYQRYYYOR-UHFFFAOYSA-K scandium(iii) trifluoromethanesulfonate Chemical compound [Sc+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F HZXJVDYQRYYYOR-UHFFFAOYSA-K 0.000 claims description 2
- IMIUDLLSPLZPNS-UHFFFAOYSA-J titanium(4+) trifluoromethanesulfonate Chemical compound [Ti+4].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F IMIUDLLSPLZPNS-UHFFFAOYSA-J 0.000 claims description 2
- OHKFHOBMOBFERQ-DFWYDOINSA-N [Se].CN[C@@H](C[SeH])C(O)=O Chemical compound [Se].CN[C@@H](C[SeH])C(O)=O OHKFHOBMOBFERQ-DFWYDOINSA-N 0.000 abstract description 12
- 239000002994 raw material Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract description 2
- 238000001308 synthesis method Methods 0.000 abstract description 2
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 239000012065 filter cake Substances 0.000 description 15
- 238000005406 washing Methods 0.000 description 15
- 238000001291 vacuum drying Methods 0.000 description 13
- -1 Sodium chloroalanine diselenide Chemical compound 0.000 description 7
- 230000006837 decompression Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 229910052711 selenium Inorganic materials 0.000 description 6
- 239000011669 selenium Substances 0.000 description 6
- TYZYNGFWGHGRBZ-REOHCLBHSA-N (2s)-2-(chloroamino)propanoic acid Chemical compound ClN[C@@H](C)C(O)=O TYZYNGFWGHGRBZ-REOHCLBHSA-N 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 5
- ZKZBPNGNEQAJSX-REOHCLBHSA-N L-selenocysteine Chemical compound [SeH]C[C@H](N)C(O)=O ZKZBPNGNEQAJSX-REOHCLBHSA-N 0.000 description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 3
- UQBOJOOOTLPNST-UHFFFAOYSA-N Dehydroalanine Chemical class NC(=C)C(O)=O UQBOJOOOTLPNST-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000003912 environmental pollution Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 3
- 235000016491 selenocysteine Nutrition 0.000 description 3
- 229940055619 selenocysteine Drugs 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- BBJFKAGVAKGYNS-UHFFFAOYSA-N 2,2-dibromopropanenitrile Chemical compound CC(Br)(Br)C#N BBJFKAGVAKGYNS-UHFFFAOYSA-N 0.000 description 2
- FNBDGJYPCPWKES-UHFFFAOYSA-N 2-selanylpropanal Chemical compound CC(C=O)[SeH] FNBDGJYPCPWKES-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- PPXAQNPNOPCBRG-UHFFFAOYSA-M [Se](=O)(=O)(OC)[O-].[Na+] Chemical group [Se](=O)(=O)(OC)[O-].[Na+] PPXAQNPNOPCBRG-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- MQUNPMBEKMVOHA-UHFFFAOYSA-N (sodiodiselanyl)sodium Chemical compound [Na][Se][Se][Na] MQUNPMBEKMVOHA-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- JMPVTFHGWJDSDV-UHFFFAOYSA-N 2-amino-3-methylselanylpropanoic acid hydrochloride Chemical compound Cl.C[Se]CC(N)C(O)=O JMPVTFHGWJDSDV-UHFFFAOYSA-N 0.000 description 1
- QSKPIOLLBIHNAC-UHFFFAOYSA-N 2-chloro-acetaldehyde Chemical compound ClCC=O QSKPIOLLBIHNAC-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 108010063599 Glycine reductase Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000011845 Iodide peroxidase Human genes 0.000 description 1
- 108010036012 Iodide peroxidase Proteins 0.000 description 1
- 229930182853 L-selenocysteine Natural products 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- IZUKXDODICQCQT-DFWYDOINSA-N N[C@@H](C[Se]C)C(=O)O.[Se] Chemical compound N[C@@H](C[Se]C)C(=O)O.[Se] IZUKXDODICQCQT-DFWYDOINSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 1
- 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 125000003180 beta-lactone group Chemical group 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052752 metalloid Inorganic materials 0.000 description 1
- QPNCVEYSDIQVJJ-VKHMYHEASA-N methyl (2s)-2-(chloroamino)propanoate Chemical compound COC(=O)[C@H](C)NCl QPNCVEYSDIQVJJ-VKHMYHEASA-N 0.000 description 1
- APKHDKJWSHYLEU-UHFFFAOYSA-N methylselenol Chemical class [SeH]C APKHDKJWSHYLEU-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical class [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention aims to provide a synthesis method of selenium methyl selenocysteine, which is used for conveniently and simply synthesizing the selenium methyl selenocysteine by using simple and easily obtained raw materials. The method comprises the following steps: adding solvent and triflate into a system after esterification, dropwise adding methyl selenol under stirring and heating, reacting for 1-3 hours under the condition, concentrating and removing the solvent, adjusting the pH of a water system to 1-3, stirring for 1-3 hours at 50-100 ℃, neutralizing the pH at room temperature to 6-8, stirring for 0.5-2 hours, filtering to obtain crude selenium methyl selenocysteine, and recrystallizing to obtain the target compound. The method is carried out under mild reaction conditions, and has the characteristics of high activity, good selectivity, high yield, low toxicity and the like.
Description
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a synthesis method of selenomethylselenocysteine.
Background
Selenium is an essential trace element of a human body, is an important component of various enzymes of the human body, has various functions of resisting oxidation, preventing cancer, detoxifying, promoting growth, improving immunity and the like, and once the body lacks selenium, the selenium can directly cause the occurrence of various diseases such as cardiovascular and cerebrovascular diseases, hypertension, metabolic syndrome, gastrointestinal diseases, diabetes, asthma, parkinsonism, liver diseases, cancers and the like, so that the great effect of the selenium on human health is not replaced by other substances.
L-selenocysteine (Selenocysteine, CAS: 10236-58-5) is the predominant form of selenium in proteins, which is present in a few enzymes such as glutathione peroxidase, thyroxine 5' -deiodinase, thioredoxin reductase, formate dehydrogenase, glycine reductase, and some hydrogenases, among others. Selenium cysteine has a structure similar to cysteine except that the sulfur atom is replaced with selenium. Selenocysteine is currently considered as the 21 st standard amino acid of human beings, is the only amino acid containing metalloid elements, and has wide research significance. At present, the synthesis of selenium methyl selenocysteine mainly comprises the following methods:
(1) Sodium chloroalanine diselenide method: firstly, reacting chloralanine with sodium diselenide to generate selenocysteine, then, reducing and cracking by using metallic sodium/liquid ammonia (-70 ℃), and then, alkylating by using methyl iodide to obtain selenomethylselenocysteine. The method involves ultralow temperature and active metal sodium, has strict reaction conditions, high requirements on process equipment, high price of chloroalanine raw materials and high production cost (methods enzymol, 1987,143,240-243; J.Med. Chem.,1996,39,2040-2046)
(2) Methylselenylacetaldehyde method: the method is a hydantoin imitation method, which is to prepare methylselenylacetaldehyde by the reaction of methylselenolate and chloroacetaldehyde, then to form methylselenomethylhydantoin by cyclization with cyanide, then to obtain selenomethylselenocysteine by alkali hydrolysis ring opening and acidification. The method has long reaction steps, and the use of highly toxic cyanide has great harm to the environment and human health. (CN 200610124942.6)
(3) Synthesis of alpha-amino acrylic acid derivative: firstly, the beta-methylseleno-alpha-amino acrylic acid derivative is produced by the addition reaction of methyl selenol or methyl selenol salt aqueous solution and alpha-amino acrylic acid derivative, then the ester compound in the derivative is hydrolyzed by alkali, hydrochloric acid or sulfuric acid is acidified to obtain the carboxylic acid compound, then the N-acyl group in the derivative is heated and hydrolyzed by hydrochloric acid or sulfuric acid to remove the beta-methylseleno-alpha-amino propionic acid hydrochloride or sulfate, and finally the selenium methylselenocysteine is obtained by neutralization by triethylamine or ammonia gas. The method has the advantages of high price of the raw material alpha-amino acrylic acid derivative and high production cost. (CN 200710051362.3)
(4) N-Boc-protected serine method: the tert-butoxyacyl serine and azodicarboxylic acid diester react in the presence of trialkyl (aryl) phosphine or phosphite to generate beta-lactone, then react with methyl selenol or its salt to generate tert-butoxyacyl protected selenomethylselenocysteine, and finally deprotecting to obtain the product. The method has the advantages of difficult preparation of the tert-butoxyacyl serine-beta-lactone as the reaction raw material, high price of the involved reaction raw material and protective agent, long reaction time and low yield. (EP 1205471,2001)
(5) Sodium methylselenate substitution chloroalanine method: and replacing chlorine in the chloralanine or chloralanine methyl ester with sodium methyl selenate to obtain selenomethylselenocysteine. The method has high price of the raw material of the chloralanine and high production cost.
(US6794537B1,2004)
(6) Substitution and ammonolysis method of sodium methylselenol and dibromopropionitrile: firstly, a selenite salt selectively reacts with 2, 3-dihalopropionitrile in a nucleophilic substitution reaction to produce 2-halogen-3-methylselenopropionitrile, then acidolysis is carried out to produce 2-halogen-3-methylselenopropionic acid, and finally, selenomethylselenocysteine is obtained by ammoniation. In the method, the preparation of the substrate dibromopropionitrile is that acrylonitrile is added with liquid bromine, a large amount of liquid bromine is used, the environmental pollution is serious, and the equipment requirement is high; the nucleophilic substitution reaction of selenoalkoxide and substrate has poor selectivity and low yield, and is not suitable for industrial production.
(CN201010107900.8)
Disclosure of Invention
The invention aims to provide a nucleophilic substitution reaction system with high efficiency and high activity, which is used for conveniently and simply synthesizing selenomethylselenocysteine through simple and easily obtained raw materials. The trifluoro methanesulfonate is used as a nucleophilic substitution catalyst of hydroxyl in a Lewis acid catalytic substrate, so that efficient alkylation reaction is realized, and the selectivity is as high as 99.5%. The catalyst has extremely strong thermodynamic and chemical stability, is widely applied to the market, and has low cost and little environmental pollution. The method is carried out under mild reaction conditions, and has the characteristics of high activity, good selectivity, high yield, low toxicity and the like.
The invention provides a method for synthesizing selenomethylselenocysteine, which comprises the following steps: adding solvent and triflate into serine methyl ester, heating to 0-80 ℃ under stirring, dropwise adding methyl selenol, after finishing the reaction for 1-5 hours, concentrating to remove the solvent, regulating the pH of a water system to 1-3, keeping stirring for 1-3 hours at 50-100 ℃, neutralizing the pH at room temperature to 6-8, keeping stirring for 0.5-2 hours, cooling the system to room temperature, filtering out solid which is crude product of selenomethylselenocysteine, adding the crude product into water for recrystallization, filtering, washing a filter cake with a small amount of ethanol, and drying to obtain the target compound.
The mass ratio of the solvent to serine methyl ester in the reaction is as follows: 2-5:1; the molar ratio of the triflate to the serine methyl ester is 0.025-0.005:1, the mass ratio of the methyl selenol to the serine methyl ester is 1-2:1;
The reaction equation is:
the reaction solvent is one or two of dichloromethane, dichloroethane, tetrahydrofuran, acetonitrile and dioxane;
The triflate is one of silver triflate, zinc triflate, aluminum triflate, scandium triflate, titanium triflate, cerium triflate, indium triflate, bismuth triflate and copper triflate;
The crude product of the selenomethylselenocysteine is red or yellow crystal;
The recrystallization solvent is one or more of methanol, ethanol, acetone, water and ethyl acetate;
In summary, under the condition of the invention, the step of synthesizing the target compound is concise, the selenomethylselenoamino acid can be directly synthesized by serine methyl ester through one-step reaction, the chemical yield of the reaction is improved, the chemical yield can reach 74-83%, and meanwhile, the dosage of the methylselenol is reduced (0.82 tons of methylselenol are needed for producing 1 ton of product); the method can reduce the size of equipment, reduce energy consumption, reduce environmental pollution, reduce the generation of byproducts, reduce the corrosion degree of the equipment and prolong the service life of the equipment.
Drawings
The selenium methyl selenocysteine nuclear magnetic hydrogen spectrum is shown in figure 1.
1H NMR(400MHz,Deuterium Oxide)δ3.88(dd,J=7.0,4.6Hz,1H),3.27–2.78 (m,2H),1.97(s,2H).
Detailed Description
The invention is illustrated by the following examples.
Example 1
200.0Ml of dichloroethane is added into a 1.0 liter four-neck flask, 100.0g of serine methyl ester and 0.5mol% of trifluoro methyl sulfonate are added under stirring, the system is heated to 60 ℃, 220.0g of dichloroethane solution containing methyl selenol (104.0 g) is added dropwise, the reaction is carried out for 2 hours under the condition of keeping the temperature, the solvent is removed by decompression and concentration, 300.0g of water is added, 6N hydrochloric acid is added under stirring to adjust the pH value of the system to 1, the reaction is carried out for 1.5 hours under the condition of heating to 80 ℃, the temperature is reduced to room temperature, 10% sodium hydroxide is added to adjust the pH value to 7, after the stirring is kept for 1 hour, the filtration is carried out, a little ethanol is used for washing a filter cake, and the yellow or red solid is 142.2g of selenium methyl selenocysteine crude product after vacuum drying.
Adding 100.0g of the crude selenomethylselenocysteine into a 500.0ml reaction bottle, adding 250.0g of water, stirring and heating to 80 ℃, cooling to 50 ℃ after the system is dissolved, dropwise adding 50.0g of ethanol, continuously cooling to room temperature, keeping for 1 hour, filtering, washing a filter cake with a small amount of ethanol, and vacuum drying to obtain 89.4g of selenomethylselenocysteine.
Example 2
200.0Ml of acetonitrile is added into a 1.0 liter four-neck flask, 100.0 g of serine methyl ester and 0.5mol% of aluminum triflate are added under stirring, the system is heated to 60 ℃, 220g of acetonitrile solution of methyl selenol (104.0 g containing methyl selenol) is added dropwise, the reaction is carried out for 2 hours under the condition that the temperature is maintained, the solvent is removed by decompression concentration, 300.0g of water is added, 6N hydrochloric acid is added under stirring to adjust the pH of the system to 1, the reaction is carried out for 2.0 hours under the condition that the temperature is 70 ℃, the temperature is reduced to room temperature, 10% sodium hydroxide is added to adjust the pH to 6.8, after the stirring is maintained for 1 hour, the filtration is carried out, a little ethanol is used for washing a filter cake, and the yellow or red solid is 137.6g of selenium methyl selenocysteine crude product after vacuum drying.
Adding 100.0g of the crude selenomethylselenocysteine into a 500.0ml reaction bottle, adding 250.0g of methanol, stirring and heating to 80 ℃, cooling to 50 ℃ after the system is dissolved, dropwise adding 50.0g of acetone, continuously cooling to room temperature, keeping for 1 hour, filtering, washing a filter cake with a small amount of ethanol, and vacuum drying to obtain 89.2g of selenomethylselenocysteine.
Example 3
200.0Ml of dichloroethane is added into a 1.0 liter four-neck flask, 100.0g of serine methyl ester and 1.0mol% of trifluoro methyl sulfonate are added under stirring, the system is heated to 60 ℃, 220g of dichloroethane solution containing methyl selenol (104.0 g) is dripped, the reaction is carried out for 2 hours under the condition of keeping the temperature, the solvent is removed by decompression concentration, 300.0g of water is added, 6N hydrochloric acid is added under stirring to adjust the pH of the system to 1, the reaction is carried out for 1.5 hours under the condition of heating to 60 ℃, the temperature is reduced to room temperature, 10% sodium hydroxide is added to adjust the pH to 6.5, after the stirring is kept for 1 hour, the filtration is carried out, a little ethanol is used for washing a filter cake, and the yellow or red solid is 143.1g of selenium methyl selenocysteine crude product after vacuum drying.
Adding 100.0g of the crude selenomethylselenocysteine into a 1.0L reaction bottle, adding 600.0g of ethyl acetate, stirring and heating to 80 ℃, cooling to room temperature after the system is dissolved, keeping the temperature for 1 hour, filtering, washing a filter cake with a small amount of ethanol, and vacuum drying to obtain 83.5g of selenomethylselenocysteine.
Example 4
200.0Ml of tetrahydrofuran is added into a 1.0 liter four-neck flask, 100.0g of serine methyl ester and 1.5mol% of indium triflate are added under stirring, the system is heated to 65 ℃, 220g of tetrahydrofuran solution of methyl selenol (104.0 g containing methyl selenol) is added dropwise, the reaction is carried out for 2 hours under the condition that the temperature is maintained, the solvent is removed by decompression concentration, 300.0g of water is added, 6N hydrochloric acid is added under stirring to adjust the pH of the system to 1, the reaction is carried out for 1.5 hours under the condition that the temperature is heated to 80 ℃, the temperature is reduced to room temperature, 10% sodium hydroxide is added to adjust the pH to 7.5, after the stirring is maintained for 1 hour, the filtration is carried out, a little ethanol is used for washing a filter cake, and vacuum drying is carried out to obtain yellow or red solid which is 134.5g of selenium methyl selenocysteine crude product.
Adding 100.0g of the crude selenomethylselenocysteine into a 1.0L reaction bottle, adding 500.0g of water, stirring and heating to 80 ℃, cooling to room temperature after the system is dissolved, keeping for 1 hour, filtering, washing a filter cake with a small amount of acetone, and vacuum drying to obtain 82.3g of selenomethylselenocysteine.
Example 5
200.0Ml of dichloroethane is added into a 1.0 liter four-neck flask, 100.0 g of serine methyl ester and 2.5mol% of copper triflate are added under stirring, the system is heated to 70 ℃,220 g of dichloroethane solution containing methyl selenol (104.0 g) is added dropwise, the reaction is carried out for 2 hours under the condition that the temperature is maintained, the solvent is removed by decompression concentration, 300.0g of water is added, 6N hydrochloric acid is added under stirring to adjust the pH of the system to 3, the reaction is carried out for 1.5 hours under the condition that the temperature is heated to 80 ℃, the temperature is reduced to room temperature, 10% sodium hydroxide is added to adjust the pH to 7, after the stirring is kept for 1 hour, the filtration is carried out, a little ethanol is used for washing a filter cake, and the yellow or red solid is 126.9g of selenium methyl selenocysteine crude product after vacuum drying.
Adding 100.0g of the crude selenomethylselenocysteine into a 500.0ml reaction bottle, adding 250.0g of water, stirring and heating to 80 ℃, cooling to 50 ℃ after the system is dissolved, dropwise adding 50.0g of ethanol, continuously cooling to room temperature, keeping for 1 hour, filtering, washing a filter cake with a small amount of ethanol, and vacuum drying to obtain 88.6g of selenomethylselenocysteine.
Example 6
200.0Ml of methylene dichloride is added into a 1.0 liter four-neck flask, 100.0g of serine methyl ester and 0.5mol% of zinc triflate are added under stirring, the system is heated to 45 ℃, 200.0g of methylene dichloride solution containing methyl selenol (104.0 g) is added dropwise, the reaction is carried out for 2 hours under the condition that the temperature is maintained, the solvent is removed by decompression concentration, 300.0g of water is added, 6N hydrochloric acid is added under stirring to adjust the pH of the system to 1, the reaction is carried out for 1.5 hours under the condition that the temperature is heated to 80 ℃, the temperature is reduced to room temperature, 10% sodium hydroxide is added to adjust the pH to 7, after the stirring is maintained for 1 hour, the filtration is carried out, a little ethanol is used for washing a filter cake, and a yellow or red solid is obtained, namely, the selenium methyl selenocysteine crude product is 140.2g.
Adding 100.0g of the crude selenomethylselenocysteine into a 500.0ml reaction bottle, adding 250.0g of methanol, stirring and heating to 80 ℃, cooling to room temperature after the system is dissolved, keeping for 1 hour, filtering, washing a filter cake with a small amount of methanol, and vacuum drying to obtain 83.6g of selenomethylselenocysteine.
Example 7
200.0Ml of dioxane is added into a 1.0 liter four-neck flask, 100.0g of serine methyl ester and 0.5mol% of silver triflate are added under stirring, the system is heated to 65 ℃, 220.0g of dioxane solution of methyl selenol (containing 104.0g of methyl selenol) is added dropwise, the reaction is carried out for 2 hours under the condition that the temperature is maintained, the solvent is removed through decompression and concentration, 300.0g of water is added, 6N hydrochloric acid is added under stirring to adjust the pH value of the system to 1, the reaction is carried out for 1.5 hours under the condition that the temperature is heated to 80 ℃, the temperature is reduced to the room temperature, 10% sodium hydroxide is added to adjust the pH value to 7, the mixture is kept under stirring for 1 hour, the mixture is filtered, a little ethanol is used for washing a filter cake, and the yellow or red solid is 123.1g of selenium methyl selenocysteine crude product after vacuum drying.
Adding 100.0g of the crude selenomethylselenocysteine into a 500.0ml reaction bottle, adding 200.0g of water, stirring and heating to 80 ℃, cooling to 50 ℃ after the system is dissolved, dropwise adding 100.0g of ethanol, continuously cooling to room temperature, keeping for 1 hour, filtering, washing a filter cake with a small amount of ethanol, and vacuum drying to obtain 80.4g of selenomethylselenocysteine.
Claims (4)
1. A method for synthesizing selenomethylselenocysteine is characterized in that:
(1) Adding solvent and triflate into serine methyl ester, and heating to 45-80deg.C under stirring;
(2) Dropwise adding methyl selenol, keeping the reaction for 1 to 5 hours after the adding, and concentrating to remove the solvent;
(3) Regulating pH of the system to 1-3 with 6N hydrochloric acid, and stirring at 50-100deg.C for 1-3 hr;
(4) Cooling to room temperature, neutralizing pH to 6-8 with 10% sodium hydroxide, and stirring for 0.5-2 hr;
(5) Filtering out solid to obtain crude selenomethylselenocysteine, and recrystallizing the crude selenomethylselenocysteine;
the mass ratio of the solvent to serine methyl ester in the reaction is as follows: 2-5:1;
The molar ratio of the triflate to the serine methyl ester is 0.025-0.005:1, a step of;
The mass ratio of the methyl selenol to the serine methyl ester is 1-2:1;
The reaction equation is:
The triflate is one or more of silver triflate, zinc triflate, aluminum triflate, scandium triflate, titanium triflate, cerium triflate, indium triflate, bismuth triflate and copper triflate.
2. The method for synthesizing selenomethylselenocysteine according to claim 1, wherein: the solvent is one or more of dichloromethane, dichloroethane, tetrahydrofuran, acetonitrile and dioxane.
3. The method for synthesizing selenomethylselenocysteine according to claim 1, wherein: the crude product of the selenomethylselenocysteine is red or yellow crystal.
4. The method for synthesizing selenomethylselenocysteine according to claim 1, wherein: the recrystallization solvent is one or more of methanol, ethanol, acetone, water and ethyl acetate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111134725.6A CN115872911B (en) | 2021-09-27 | 2021-09-27 | Method for synthesizing selenomethylselenocysteine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111134725.6A CN115872911B (en) | 2021-09-27 | 2021-09-27 | Method for synthesizing selenomethylselenocysteine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115872911A CN115872911A (en) | 2023-03-31 |
CN115872911B true CN115872911B (en) | 2024-06-11 |
Family
ID=85762893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111134725.6A Active CN115872911B (en) | 2021-09-27 | 2021-09-27 | Method for synthesizing selenomethylselenocysteine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115872911B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102558005A (en) * | 2012-01-11 | 2012-07-11 | 张家港阿拉宁生化技术有限公司 | Environmentally-friendly method for synthesizing selenomethionine |
CN110683976A (en) * | 2019-11-04 | 2020-01-14 | 济源市万洋华康生物科技有限公司 | Method for preparing (R) -selenium methyl selenocysteine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160221941A1 (en) * | 2015-02-02 | 2016-08-04 | University Of Vermont And State Agricultural College | Selenocystine derivatives, alpha-methylselenocysteine, alpha-methylselenocysteine derivatives, and methods of making and using same |
-
2021
- 2021-09-27 CN CN202111134725.6A patent/CN115872911B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102558005A (en) * | 2012-01-11 | 2012-07-11 | 张家港阿拉宁生化技术有限公司 | Environmentally-friendly method for synthesizing selenomethionine |
CN110683976A (en) * | 2019-11-04 | 2020-01-14 | 济源市万洋华康生物科技有限公司 | Method for preparing (R) -selenium methyl selenocysteine |
Also Published As
Publication number | Publication date |
---|---|
CN115872911A (en) | 2023-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1834092A (en) | Prepn. of pramipexole | |
US3733352A (en) | Preparation of d-threo-1-p-methyl-sulfonylphenyl-2-dichloro-acet-amidopropane-1,3-diol | |
CN115872911B (en) | Method for synthesizing selenomethylselenocysteine | |
JPH0150704B2 (en) | ||
CN113831237A (en) | Synthesis method of 9-anthracenecarboxylic acid | |
CN115572272B (en) | Preparation method of febuxostat and aldehyde ester intermediate thereof | |
CN113773229B (en) | Alpha, beta-unsaturated amino acid derivative and DL-selenium-methyl seleno amino acid derivative, synthetic method and application thereof | |
CN113698331B (en) | Synthesis method of L-selenium-methyl selenocysteine | |
CN106187818B (en) | A kind of method for preparing cancer therapy drug Vorinostat | |
CN111574458B (en) | Synthetic method of ergothioneine | |
CN101735242A (en) | Method for preparing D-(+)-biotin intermediate | |
US4154757A (en) | Process for the manufacture of p-hydroxybenzyl cyanide | |
CN113173860B (en) | Preparation method of 2-methylalanine | |
CN115073322B (en) | Preparation method of 2-oxime ethyl cyanoacetate potassium salt | |
US5530159A (en) | Preparation of α-alaninediacetic acid or its alkali metal or ammonium salts | |
CN115872882B (en) | Synthesis method of 3-chloro-alanine | |
US4072687A (en) | Process for producing 2-amino-(2)-thiazoline-4-carboxylic acid | |
JPS60152469A (en) | Preparation of cis-diester derivative | |
JP2007261982A (en) | Method for producing quinazolin-2,4-dione derivative | |
CN111187293A (en) | Preparation method of S-3-trimethylsilyl alanine | |
CN106008267B (en) | A kind of preparation method of cancer therapy drug Vorinostat | |
CN116354820A (en) | Preparation method of carbidopa process impurities | |
RU2609868C1 (en) | Method for production of amino-2-hydroxy-3-chloropropane-n,n-diacetic acid | |
CN117720446A (en) | Green methionine synthesis method | |
CN116924950A (en) | Preparation method of 2-hydroxy-4-substituted thiobutyric acid and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |